Brief: Mendus Reports Positive Phase 1B Alison Trial Results In Hgsoc At Asco 2026
02/06/2026 07:03
BRIEF-Mendus Reports Positive Phase 1B Alison Trial Results In Hgsoc At Asco 2026 June 2 (Reuters) - Mendus AB (publ) IMMUN.ST:
REPORTS POSITIVE PHASE 1B ALISON TRIAL RESULTS IN HGSOC AT ASCO 2026
FIVE ALISON TRIAL PARTICIPANTS REMAIN PROGRESSION-FREE AT LONG-TERM FOLLOW-UP
ALISON TRIAL PART OF MENDUS AND UMCG COLLABORATION ON GYNECOLOGICAL CANCER IMMUNOTHERAPIES
Source text: ID:nMFNc4rnCs
Further company coverage: IMMUN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))